Blueprint Medicines Corp
BPMCDelisted Jul 18, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001597264
Blueprint Medicines Corp was delisted on Jul 18, 2025; its insiders filed their last Form 4 on Jul 21, 2025; 356 institutions reported holding it in 13F filings for Q2 2025, worth $8.65B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q2 2025
Institutional positions in Blueprint Medicines Corp as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
BPMC is no longer listed, so this page shows Q2 2025. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 356
- +5 vs. Q1 2025
- Shares held
- 67.5M
- −1.61M (−2.3%) vs. Q1 2025
- Total value
- $8.65B
- +$2.54B (+41.5%) vs. Q1 2025
- New holders
- 111
- 94 more added
- Sold out
- 106
- 118 more reduced
2 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BPMC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 4 | $129 |
| Q1 2026 | 6 | $38.6K |
| Q4 2025 | 8 | $2.57M |
| Q3 2025 | 12 | $2.58M |
| Q2 2025 | 356 | $8.65B |
| Q1 2025 | 353 | $6.12B |
| Q4 2024 | 346 | $5.86B |
| Q3 2024 | 319 | $6.04B |
| Q2 2024 | 305 | $7.15B |
| Q1 2024 | 282 | $6.25B |
| Q4 2023 | 260 | $5.91B |
| Q3 2023 | 220 | $3.25B |
| Q2 2023 | 222 | $4.03B |
| Q1 2023 | 215 | $2.84B |
| Q4 2022 | 223 | $2.74B |
| Q3 2022 | 240 | $4.15B |
| Q2 2022 | 237 | $3.19B |
| Q1 2022 | 248 | $3.82B |
| Q4 2021 | 280 | $6.32B |
| Q3 2021 | 289 | $6.13B |
| Q2 2021 | 281 | $5.14B |
| Q1 2021 | 264 | $5.69B |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Blueprint Medicines Corp; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Soros Fund Management LLCSuperinvestorSoros Fund Management | 250,000 | $32.0M | 0.55% | +250,000 | New |
| Affinity Asset Advisors, LLC | 250,000 | $32.0M | 4.74% | +250,000 | New |
| Polar Asset Management Partners Inc. | 262,964 | $33.7M | 0.84% | +262,964 | New |
| Novo Holdings A/S | 264,956 | $34.0M | 2.40% | +36,152+15.8% | Added |
| Cinctive Capital Management LP | 265,000 | $34.0M | 1.90% | +233,806+749.5% | Added |
| Janus Henderson Group PLC | 268,928 | $34.5M | 0.02% | +240,179+835.4% | Added |
| Bellevue Group AG | 284,900 | $36.5M | 0.80% | +284,900 | New |
| Slotnik Capital, LLC | 292,694 | $37.5M | 15.11% | +292,694 | New |
| Millennium Management LLC | 295,879 | $37.9M | 0.03% | −395,516−57.2% | Reduced |
| TIG Advisors, LLC | 305,097 | $39.1M | 2.13% | +305,097 | New |
| Whitebox Advisors LLC | 310,001 | $39.7M | 1.08% | +310,001 | New |
| Readystate Asset Management LP | 329,831 | $42.3M | 1.76% | +329,831 | New |
| Avoro Capital Advisors LLC | 375,000 | $48.1M | 0.84% | −3,475,000−90.3% | Reduced |
| Quadrature Capital Ltd | 382,677 | $49.1M | 0.85% | +382,677 | New |
| LMR Partners LLP | 395,857 | $50.7M | 0.79% | +385,168+3,603.4% | Added |
| Clearbridge Investments, LLC | 405,708 | $52.0M | 0.04% | −265,909−39.6% | Reduced |
| JPMorgan Chase & Co | 418,060 | $53.6M | 0.00% | −2,088,454−83.3% | Reduced |
| Wellington Management Group LLP | 435,976 | $55.9M | 0.01% | −2,637,330−85.8% | Reduced |
| Vivaldi Asset Management, LLC | 456,068 | $58.5M | 3.95% | +456,068 | New |
| Brown Advisory Inc | 458,559 | $58.8M | 0.08% | −123,305−21.2% | Reduced |
| Tudor Investment Corp Et Al | 468,623 | $60.1M | 0.45% | +446,612+2,029.0% | Added |
| Highland Capital Management Fund Advisors, L.P. | 476,742 | $61.1M | 5.82% | +476,742 | New |
| Nuveen, LLC | 488,612 | $62.6M | 0.02% | +220,952+82.5% | Added |
| Balyasny Asset Management LLC | 505,957 | $64.9M | 0.15% | +445,675+739.3% | Added |
| Invesco Ltd. | 511,091 | $65.5M | 0.01% | −473,583−48.1% | Reduced |
| Man Group plc | 516,258 | $66.2M | 0.14% | −3,479−0.7% | Reduced |
| Woodline Partners LP | 531,880 | $68.2M | 0.36% | −8,858−1.6% | Reduced |
| Voloridge Investment Management, LLC | 558,768 | $71.6M | 0.26% | +548,633+5,413.3% | Added |
| FMR LLC | 558,960 | $71.6M | 0.00% | −874,209−61.0% | Reduced |
| Charles Schwab Investment Management Inc | 561,159 | $71.9M | 0.01% | −38,562−6.4% | Reduced |
| Northern Trust Corp | 568,924 | $72.9M | 0.01% | −20,635−3.5% | Reduced |
| Bank of America Corp | 647,487 | $83.0M | 0.01% | −69,419−9.7% | Reduced |
| Renaissance Technologies LLC | 674,500 | $86.5M | 0.12% | +674,500 | New |
| Eventide Asset Management, LLC | 728,821 | $93.4M | 1.64% | −133,728−15.5% | Reduced |
| Magnetar Financial LLC | 730,047 | $93.6M | 0.45% | +725,479+15,881.8% | Added |
| Alliancebernstein L.P. | 765,387 | $98.1M | 0.03% | −430,853−36.0% | Reduced |
| Syquant Capital SAS | 805,603 | $103.3M | 34.24% | +805,603 | New |
| Goldman Sachs Group Inc | 891,287 | $114.2M | 0.02% | −35,381−3.8% | Reduced |
| Macquarie Group Ltd | 922,167 | $118.2M | 0.15% | −364,730−28.3% | Reduced |
| Morgan Stanley | 1,031,170 | $132.2M | 0.01% | +462,471+81.3% | Added |
| Davidson Kempner Capital Management LP | 1,035,100 | $132.7M | 2.02% | +1,035,100 | New |
| Alpine Associates Management Inc. | 1,060,307 | $135.9M | 7.27% | +1,060,307 | New |
| Beryl Capital Management LLC | 1,067,224 | $136.8M | 20.60% | +1,067,224 | New |
| Norges Bank | 1,074,936 | $137.8M | 0.02% | +472,009+78.3% | Added |
| Glazer Capital, LLC | 1,331,300 | $170.6M | 6.10% | +1,331,300 | New |
| Price T Rowe Associates Inc | 1,464,968 | $187.8M | 0.02% | −3,950,869−73.0% | Reduced |
| Geode Capital Management, LLC | 1,541,013 | $197.6M | 0.01% | +18,366+1.2% | Added |
| Barclays PLC | 1,556,918 | $199.6M | 0.08% | +1,427,323+1,101.4% | Added |
| UBS Oconnor LLC | 1,713,587 | $219.6M | 6.00% | +1,698,722+11,427.7% | Added |
| FIL Ltd | 1,759,500 | $225.5M | 0.19% | +1,759,500 | New |
| UBS Group AG | 2,167,028 | $277.8M | 0.06% | +1,953,223+913.6% | Added |
| State Street Corp | 2,230,980 | $286.0M | 0.01% | −453,137−16.9% | Reduced |
| HBK Investments L P | 3,200,924 | $410.3M | 7.29% | +3,200,924 | New |
| Pentwater Capital Management LP | 3,900,000 | $499.9M | 6.38% | +3,900,000 | New |
| BlackRock, Inc. | 6,118,428 | $784.3M | 0.02% | −592,280−8.8% | Reduced |
| Vanguard Group Inc | 6,416,603 | $822.5M | 0.01% | −223,920−3.4% | Reduced |
| T. Rowe Price Investment Management, Inc. | 0 | $0 | 0.00% | −1,302,810−100.0% | Sold out |
| Alkeon Capital Management LLC | 0 | $0 | 0.00% | −900,628−100.0% | Sold out |
| Hood River Capital Management LLC | 0 | $0 | 0.00% | −900,205−100.0% | Sold out |
| Siren, L.L.C. | 0 | $0 | 0.00% | −726,167−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −570,402−100.0% | Sold out |
| Polar Capital Holdings Plc | 0 | $0 | 0.00% | −541,379−100.0% | Sold out |
| Braidwell LP | 0 | $0 | 0.00% | −439,968−100.0% | Sold out |
| Emerald Advisers, LLC | 0 | $0 | 0.00% | −401,644−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −388,986−100.0% | Sold out |
| Jennison Associates LLC | 0 | $0 | 0.00% | −348,817−100.0% | Sold out |
| Casdin Capital, LLC | 0 | $0 | 0.00% | −326,378−100.0% | Sold out |
| Capital Research Global Investors | 0 | $0 | 0.00% | −311,137−100.0% | Sold out |
| Lord, Abbett & Co. LLC | 0 | $0 | 0.00% | −288,472−100.0% | Sold out |
| Sofinnova Investments, Inc. | 0 | $0 | 0.00% | −261,039−100.0% | Sold out |
| Emerald Mutual Fund Advisers Trust | 0 | $0 | 0.00% | −250,158−100.0% | Sold out |
| Driehaus Capital Management LLC | 0 | $0 | 0.00% | −242,938−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −183,947−100.0% | Sold out |
| Integral Health Asset Management, LLC | 0 | $0 | 0.00% | −145,000−100.0% | Sold out |
| Granahan Investment Management Inc | 0 | $0 | 0.00% | −144,756−100.0% | Sold out |
| Segall Bryant & Hamill, LLC | 0 | $0 | 0.00% | −135,909−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −113,904−100.0% | Sold out |
| Peregrine Capital Management LLC | 0 | $0 | 0.00% | −96,149−100.0% | Sold out |
| First Turn Management, LLC | 0 | $0 | 0.00% | −92,033−100.0% | Sold out |
| Aquilo Capital Management, LLC | 0 | $0 | 0.00% | −83,926−100.0% | Sold out |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −76,270−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −74,574−100.0% | Sold out |
| Ally Bridge Group (NY) LLC | 0 | $0 | 0.00% | −74,192−100.0% | Sold out |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −68,500−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −68,420−100.0% | Sold out |
| StemPoint Capital LP | 0 | $0 | 0.00% | −61,927−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Tri Locum Partners LP | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Mirae Asset Global ETFs Holdings Ltd. | 0 | $0 | 0.00% | −45,534−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −45,200−100.0% | Sold out |
| Patient Square Capital LP | 0 | $0 | 0.00% | −38,500−100.0% | Sold out |
| Thematics Asset Management | 0 | $0 | 0.00% | −37,601−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −37,345−100.0% | Sold out |
| Prosight Management, LP | 0 | $0 | 0.00% | −36,512−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −36,454−100.0% | Sold out |
| F/M Investments LLC | 0 | $0 | 0.00% | −33,276−100.0% | Sold out |
| Corebridge Financial, Inc. | 0 | $0 | 0.00% | −31,151−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −25,681−100.0% | Sold out |
| Moody Aldrich Partners LLC | 0 | $0 | 0.00% | −22,331−100.0% | Sold out |
| Nomura Asset Management Co Ltd | 0 | $0 | 0.00% | −21,935−100.0% | Sold out |